The State Duma adopts in the second reading a bill on the supply of blood plasma for medicines

On Tuesday, June 14, during the plenary session, the State Duma adopted in the second reading a bill aimed at expanding the possibility of supplying donated blood to manufacturers of medicines.
The Cabinet of Ministers submitted the document to the State Duma in April. It is proposed to adopt amendments to the laws on donation of blood and its components and on public-private partnership in the Russian Federation. It is proposed to introduce a mechanism for the transfer of blood plasma for the production of medicines in order to increase the volume of “domestic production of plasma medicines classified as vital and essential drugs.”
“According to the bill, blood plasma can be transferred for the production of medicines not only to medical organizations, but also to drug manufacturers unrelated to medical organizations,” the explanatory note to the document reads.
Amendments to previously adopted federal laws will allow for sending donor plasma directly to pharmaceutical plants. Russian manufacturers will receive the necessary components faster, which will enable them to increase capacity and provide drugs that the population needs.
As it became known earlier, the bill prohibits the export of donated blood, its components and plasma obtained in Russia, to other countries, except in cases when it is supplied for humanitarian aid.
“According to the amendments to the second reading, it is proposed to amend the law “On Donation of Blood and its components” with an article allowing manufacturers of donated blood to conclude agreements on the joint development of the infrastructure of the entity in charge of distribution of donated blood and its components with organizations included in the related list, as well as directly with the Russian Federation or the region of the Russian Federation, on behalf of which the founder of the organization acts. The law will prescribe the procedure for concluding such an agreement, as well as the rules of its operation. The term of the agreement may not exceed 15 years. At the same time, according to the amendments, the period for the fulfillment of the manufacturer’s obligations on the provision of equipment, construction, reconstruction and overhaul of the facility under the agreement cannot exceed three years,” TASS reports.